Eirini Kostopoulou | Clinical Medicine | Research Excellence Award

Published on by Health Scientists

Assist. Prof. Dr. Eirini Kostopoulou | Clinical Medicine | Research Excellence Award

Assistant Professor | University General Hospital of Patras | Greece

Dr. Eirini Kostopoulou is an Assistant Professor of Paediatric Endocrinology at the University of Patras School of Medicine, with advanced clinical and research training in Greece and leading academic hospitals in the United Kingdom. Her expertise spans paediatric obesity, monogenic and syndromic obesity, type one diabetes mellitus, growth and thyroid disorders, congenital hyperinsulinism, and lipid abnormalities. Her research focuses on molecular and genetic mechanisms underlying metabolic and endocrine diseases, including growth hormone signaling, oxidative stress, apoptotic pathways, and rare genetic causes of obesity, with direct translational impact on diagnosis and targeted therapies. She has authored a substantial body of peer-reviewed publications with strong citation impact and has contributed extensively through invited lectures, international collaborations, and multicenter clinical studies. Her work has advanced precision medicine approaches in paediatric endocrinology, improved early diagnosis of rare disorders, and strengthened clinical management strategies with meaningful societal and public health relevance. She has 499 citations from 77 documents with an h-index of 12.

Citation Metrics (Scopus)

800
600
400
200
0

Citations
499

Documents
77

h-index
12

🟦 Citations    🟥 Documents    🟩 h-index

View Google Scholar Profile
 View Scopus Profile

Featured Publications

Gao Yanjing | Clinical Medicine | Research Excellence Award

Published on by Health Scientists

Prof. Gao Yanjing | Clinical Medicine | Research Excellence Award

Chief Physician | Qilu Hospital of Shandong University | China

Gao Yanjing is a clinician–scientist and chief physician in gastroenterology at Qilu Hospital of Shandong University, with extensive expertise in liver cirrhosis, portal hypertension, gastrointestinal bleeding, and thrombotic complications of chronic liver disease. Trained in internal and clinical medicine, Gao has built a sustained academic career integrating patient-centered clinical practice with translational research. The work has resulted in a substantial body of peer-reviewed publications in leading international journals, with broad scholarly visibility and frequent citation within hepatology and gastroenterology research communities. Gao has led and participated in multicenter randomized clinical studies and investigator-initiated projects, and has collaborated closely with national and international institutions, including overseas academic medical centers. The research has directly informed clinical decision-making, optimized therapeutic strategies for cirrhosis-related complications, and contributed to improved patient outcomes and evidence-based gastrointestinal care. The researcher has 587 citations from 50 documents, with an h-index of 15.

Citation Metrics (Scopus)

600
400
200
0

Citations
587

Documents
50

h-index
15

🟦 Citations        🟥 Documents      🟩 h-index

View Google Scholar Profile
 View Scopus Profile

Featured Publications

Michele Ammendola | Translational Research | Research Excellence Award

Published on by Health Scientists

Prof. Dr. Michele Ammendola | Translational Research | Research Excellence Award

Professor | Magna Graecia University | Italy

Professor Michele Ammendola is a distinguished surgeon and researcher specializing in digestive and general surgery, with a particular focus on translational research in oncology and gastrointestinal disorders. He serves at the Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy, and leads the Digestive Surgery Unit. His work integrates clinical practice with advanced research methodologies, contributing to the understanding of tumor neoangiogenesis, immune system interactions, and surgical innovations. Professor Ammendola has authored numerous scientific publications in internationally indexed journals and serves on editorial boards, reflecting his scholarly influence. He maintains active collaborations with leading institutions across Europe and beyond, advancing surgical techniques and patient-centered care. His research and clinical contributions have informed both practice and policy, fostering improved outcomes in complex surgical interventions and enhancing the broader societal understanding of gastrointestinal health and cancer management. He has 2559 citations from 130 documents with an h-index of 32.

Citation Metrics (Scopus)

3,000
2,000
1,000
0

Citations
2,559

Documents
130

h-index
32

🟦 Citations         🟥 Documents      🟩 h-index


View Scopus Profile

Featured Publications

Fatemeh Molaabasi | Health Technology | Best Researcher Award

Published on by Health Scientists

Assist. Prof. Dr. Fatemeh Molaabasi | Health Technology | Best Researcher Award 

Assistant Professor | Breast Cancer Research Center, Motamed Cancer Institute, ACECR | Iran

Dr. Fatemeh Molaabasi is an accomplished scholar in analytical chemistry, biomaterials, and medical nanotechnology, serving as an Assistant Professor at the Motamed Cancer Institute, ACECR, where she contributes to the Biomaterials and Tissue Engineering and Medical Nanotechnology Research Groups. Her research advances bio-inspired nanomaterials for drug delivery, biosensing, regenerative medicine, cancer diagnostics, and theranostics, with a strong emphasis on clinically translatable platforms. She has produced a substantial body of peer-reviewed work in international journals and scholarly books and holds a record of impactful scientific contributions evidenced by a high citation profile and sustained editorial and reviewing responsibilities in leading journals. Dr. Molaabasi has pioneered innovative tools including tumor apoptosis assay platforms, viral detection systems, electrochemical biosensing strips, three-dimensional tumor models, and targeted diagnostic devices for circulating tumor cells, demonstrating excellence in merging chemistry, biology, engineering, and clinical needs. Her portfolio also includes the development of medical diagnostic kits, rapid assays, and dialysis-based devices designed to support metastatic cancer patients, reflecting a strong translational orientation toward patient-centered technology development. She has secured national funding, engaged in interdisciplinary and global research collaborations with leading academic and biomedical centers, and contributed to national innovation initiatives and industry-linked diagnostic technology development. Beyond research and innovation, she has actively served in editorial boards and scientific committees, reviewed national scientific grants, and mentored emerging researchers. Dr. Molaabasi’s work embodies a commitment to strengthening early cancer detection, precision medicine, and bio-nanotechnology infrastructure, while advancing sustainable and biocompatible nanoplatforms. Her efforts contribute to global research in cancer diagnostics and biosensors and to the development of affordable, high-performance biomedical technologies, reinforcing her role as a leader in next-generation healthcare innovation and applied nanoscience. She has 1274 citations from 55 documents with an h-index of 22.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Fathi Ganje Lou, E., Rezayan, A. H., Malekmohamadi, M., Abbasi, V., et al. (2025). Very simple and ultra-sensitive fluorescence resonance energy transfer aptasensor for turn-on C-reactive protein detection in biological matrices.

2. Feizi, F., Molaabasi, F., Ezati, M., Shamsipur, M., Mousavi, F., Roshanfekr, A., et al. (2025). Ratiometric fluorescence chiral sensors for pH monitoring and its applications in indicator paper and bioimaging. Analytical Chemistry.

3. Molaabasi, F., Mohseni, N., Hajipour-Verdom, B., Agheli, A., et al. (2025). Ultra-efficient label-free cell death detection based on multifunctional colorimetric fluorescent in-situ silver nanocluster/graphene nanohybridzyme and its application in environmental biological samples and cellular imaging. Biosensors and Bioelectronics.

4. Shahrashoob, M., Dehshiri, M., Yousefi, V., Moassesfar, M., Saberi, H., et al. (2025). Optical and electrochemical biosensors for detection of pathogens using metal nanoclusters: A systematic review. Biosensors.

5. Besharati, M., Radi, H. C., & Molaabasi, F. (2025). A highly sensitive and simple platform for enzyme-free detection of ethanol based on a nano-porous glassy carbon electrode with electrodeposited Ni nanoparticles. Russian Journal of Electrochemistry.

Tana Takacova | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Dr. Tana Takacova | Clinical Medicine | Best Researcher Award

Oncologist | Asklepios Klinik Altona | Germany

Tana Takacova is a physician-scientist specializing in hematology, oncology, and internal medicine with a distinguished academic and clinical trajectory across leading European research and tertiary care institutions. Her expertise spans immuno-oncology, molecular oncology, hematologic malignancies, and translational cancer research, supported by advanced training in oncology from a major German university and extensive postgraduate exposure to molecular biosciences in the United States. She has held clinical roles in prominent university-affiliated hospitals, progressing through multidisciplinary departments including hematology, oncology, palliative medicine, internal medicine, rheumatology, nephrology, gastroenterology, and cardiology, complemented by ongoing training as a prehospital emergency physician. Dr. Takacova has contributed to multiple international research collaborations across Germany, Denmark, Italy, and Slovakia, advancing knowledge in cancer genetics, circulating tumor DNA, oncolytic virus-checkpoint inhibitor synergies, renal cell carcinoma biomarkers, and therapy response prediction. Her peer-reviewed scholarship includes original research articles, systematic reviews, and case-based contributions in oncology and immunology, with additional manuscripts in review and development, reflecting a sustained commitment to evidence-based innovation and emerging therapeutic paradigms in precision oncology. She has presented at international oncology and pharmacology congresses and participates in global research networks and professional societies, reinforcing a truly international academic presence. Her work integrates advanced laboratory skills, clinical trial supervision, systematic review methodology, and bioinformatics-supported analysis, underscoring strong translational orientation. She has been recognized by competitive research fellowships and academic awards and contributes to open-access medical knowledge through educational initiatives such as a freely accessible hematology atlas. Fluent in multiple languages and trained across diverse health systems, she brings a global perspective, resilience in high-pressure environments, and a collaborative approach to clinical care and research leadership, driven by a commitment to advancing cancer diagnostics, therapeutic precision, and equitable patient outcomes worldwide. She has 34 citations from 4 documents with an h-index of 2.

Profile: Scopus

Featured Publications

1. Tana Takacova (2025). Paraneoplastic papillitis as a precursor to colon carcinoma: A case of unexpected vision loss leading to early cancer detection. Oncology Research and Treatment.

Miguel Garcia-Gonzalez | Translational Research | Innovative Research Award

Published on by Health Scientists

Dr. Miguel Garcia-Gonzalez | Translational Research | Innovative Research Award

Research group leader | FIDIS/IDIS | Spain

Dr. Miguel García González is a distinguished biomedical researcher and Group Leader at the Instituto de Investigación Sanitaria de Santiago (IDIS/CHUS) in Spain, specializing in Molecular Genetics and Developmental Biology of Kidney Diseases. He earned his Ph.D. in Molecular Biology from the University of Santiago de Compostela, where he developed a strong foundation in genetics, molecular mechanisms, and translational nephrology. His research focuses on understanding the genetic and molecular bases of polycystic kidney disease (PKD) and related hereditary disorders, integrating genomic, cellular, and developmental biology approaches to identify novel therapeutic targets. Dr. García González has authored more than 40 peer-reviewed publications in high-impact journals such as Nature Medicine, PNAS, Kidney International, and Human Molecular Genetics, contributing significantly to the field’s understanding of renal pathophysiology. His work has received numerous national and international research grants and awards, recognizing his excellence in scientific innovation and mentorship. He actively participates in editorial and peer-review roles for several leading journals in nephrology and molecular biology, further influencing the direction of biomedical research. In addition to his research contributions, Dr. García González is deeply committed to training young scientists, supervising doctoral and postdoctoral researchers, and fostering interdisciplinary collaboration across clinical and molecular domains. His pioneering work continues to advance precision medicine approaches in nephrology, bridging basic science discoveries with clinical applications aimed at improving outcomes for patients with genetic kidney diseases. He has 1913 citations from 50 documents with an h-index of 20.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. A comparative proteomic, transcriptomic and glycomic analysis of extracellular vesicle isolation techniques highlights ExoGAG efficiency for a more complete identification of breast milk molecular signaling pathways. (2025). Cell Communication and Signaling.

2. Therapeutic opportunities in polycystic kidney and liver disease through extracellular matrix dynamics. (2025). Biochemical Pharmacology.

3. Characterization of recurrent UMOD variants (p.C255Y and p.Q316P) in a Galician cohort: Genotype–phenotype correlation and clinical implications. (2025). Nefrología.

4. Characterization of the functional component in human milk and identification of the molecular mechanisms undergoing prematurity. (2025). Clinical Nutrition.

5. HNF1B transcription factor: Key regulator in renal physiology and pathogenesis. (2025).

Eze Ajaegbu | Infectious Diseases | Best Researcher Award

Published on by Health Scientists

Dr. Eze Ajaegbu | Infectious Diseases | Best Researcher Award 

Senior Lecturer | David Umahi Federal University of Health Sciences | Nigeria

Dr. Eze Elijah Ajaegbue is a distinguished researcher currently serving as a Researcher on Vector Control and Cancer at David Umahi Federal University of Health Sciences, Nigeria. He earned his B.Sc. in Clinical Medicine from Anambra State University, Uli, and has further enhanced his expertise with a six-month Data Science course at PORA Academy, Nigeria, complementing his strong foundation in biomedical research. Dr. Ajaegbue’s research primarily focuses on vector-borne disease control, cancer biology, and diabetes-related studies, integrating epidemiology, nutrition, and translational health sciences. Over the years, he has contributed to numerous peer-reviewed publications exploring the mechanisms of disease transmission, preventive interventions, and innovative strategies to improve patient outcomes. His dedication to scientific excellence has earned him multiple awards and recognitions for research innovation and community impact, reflecting his commitment to both academic and public health advancement. Beyond his research, Dr. Ajaegbue plays an active role in editorial and peer-review capacities for several scientific journals, ensuring the dissemination of high-quality research in his field. His work is further distinguished by extensive community engagement, where he has led programs in schools, hospitals, and local organizations to promote academic development, nutrition awareness, and health education. With a unique blend of rigorous scientific inquiry, data-driven research approaches, and strong mentorship, Dr. Ajaegbue continues to make significant contributions to health research, vector control, and community well-being, positioning himself as a leading figure in advancing public health initiatives in Nigeria and beyond. He has 54 citations from 13 documents with an h-index of 4.

Profiles: Google Scholar | Scopus

Featured Publications

1. Ajaegbu, E. E., Danga, S. P. Y., Chijoke, I. U., & Okoye, F. B. C. (2016). Mosquito adulticidal activity of the leaf extracts of Spondias mombin L. against Aedes aegypti L. and isolation of active principles. Journal of Vector Borne Diseases.

2. Osonwa, U. E., Ugochukwu, J. I., Ajaegbu, E. E., Chukwu, K. I., Azevedo, R. B., et al. (2017). Enhancement of antibacterial activity of ciprofloxacin hydrochloride by complexation with sodium cholate. Bulletin of Faculty of Pharmacy, Cairo University.

3. Eze, E. A., Danga, S. P. Y., & Okoye, F. B. C. (2014). Larvicidal activity of the leaf extracts of Spondias mombin Linn. (Anacardiaceae) from various solvents against malarial, dengue and filarial vector mosquitoes (Diptera: Culicidae). Journal of Vector Borne Diseases.

4. Lame, Y., Nukenine, E. N., Pierre, D. Y. S., Elijah, A. E., & Esimone, C. O. (2015). Laboratory evaluations of the fractions efficacy of Annona senegalensis (Annonaceae) leaf extract on immature stage development of malarial and filarial mosquito vectors. Journal of Arthropod-Borne Diseases.

5. Victor, C., Moses, O., Eze, A., Festus, O., & Charles, E. (2018). Isolation, identification, and evaluation of biological activities of Daldinia eschscholtzii, an endophytic fungus isolated from the leaves of Musa paradisiaca. GSC Biological and Pharmaceutical Sciences.